FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to medicine and aims at treating fibromyalgia syndrome. The method of treating fibromyalgia syndrome involves administering a therapeutically effective amount of a substance having structural formula 
, or its pharmaceutically acceptable salt into a mammal in need thereof, wherein Rx, R1 and R2 represent hydrogen and x is equal to 1. What is also provided is a pharmaceutical composition containing the substance having structural formula (1), or its pharmaceutically acceptable salt.
EFFECT: using the group of inventions provide the effective treatment of fibromyalgia syndrome.
13 cl, 1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF FLECAINIDE AS ANTICONNEXIN AGENT AND METHOD OF POTENTIATION OF EFFECTS OF PSYCHOTROPIC MEDICINES | 2014 |
|
RU2661026C2 |
| METHODS FOR TREATING AND PREVENTING FATIGUE | 2010 |
|
RU2567801C2 |
| METHOD OF TREATING EXCESSIVE DAYTIME SLEEPINESS (VERSIONS) | 2006 |
|
RU2417077C2 |
| CATAPLEXIS TREATMENT | 2014 |
|
RU2689984C2 |
| THERAPEUTIC AGENTS FOR THE TREATMENT OF RESTLESS LEG SYNDROME | 2019 |
|
RU2802288C2 |
| USE OF CARBAMIC ACID COMPOUND FOR PREVENTION OR TREATMENT OF FIBROMYALGIA OR FUNCTIONAL SYNDROME ASSOCIATED WITH FIBROMYALGIA | 2017 |
|
RU2753525C2 |
| USE OF AN INVERSE AGONIST H3R FOR TREATING SLEEP DISORDER IN SHIFT WORK | 2018 |
|
RU2768894C2 |
| METHOD OF TREATING ATTENTION DEFICIT/HYPERACTIVITY SYNDROME | 2010 |
|
RU2556585C2 |
| METHODS FOR TREATMENT OF DISORDERS OF CIRCADIAN SLEEP RHYTHM | 2017 |
|
RU2763493C2 |
| CARBAMATE DERIVATIVES USED FOR PAIN TREATMENT | 2002 |
|
RU2283106C2 |
